Long COVID is real, it's widespread, and it's frustrating. Months or years after acute infection, people are dealing with crushing fatigue, cognitive dysfunction (brain fog), post-exertional malaise (PEM—where activity makes symptoms dramatically worse), and a constellation of other symptoms that conventional medicine hasn't figured out how to treat. It's no wonder that people are turning to IV therapy clinics, wellness influencers, and experimental protocols. The question isn't whether Long COVID sufferers are desperate—they are. The question is: does IV therapy actually help, or are we seeing another case of a hopeful treatment outpacing the evidence?
What Long COVID Actually Is (and Why It's So Hard to Treat)
Long COVID—or post-acute sequelae of COVID-19 (PASC)—affects an estimated 10-30% of people who had COVID-19 infection, with roughly 2-3 million Americans experiencing significant functional impairment. The condition isn't simply lingering infection; most people with Long COVID test negative on viral assays months or years later. Instead, research points to post-viral inflammation, immune dysregulation, mitochondrial dysfunction, microclotting, and autonomic nervous system dysfunction—though no single mechanism fully explains the syndrome. This matters because it explains why treatments that work for acute viral infection don't work for Long COVID. Your body isn't fighting an active virus anymore; it's stuck in a maladaptive recovery state. That context is crucial when evaluating whether IV therapy—which works best for correcting deficiencies or delivering high-dose micronutrients—is the right tool for a systemic immune and metabolic problem.
The IV Protocols Clinics Are Actually Offering for Long COVID
IV therapy clinics have begun marketing several formulations specifically for Long COVID recovery. The most common include: Myers Cocktail (B vitamins, magnesium, calcium, vitamin C), high-dose vitamin C IV infusions (based on the immunomodulatory theory), NAD+ infusions (targeting mitochondrial function), glutathione IV therapy (marketed for antioxidant and immune support), and micronutrient blends tailored to reported deficiencies. Some clinics also offer IV anticoagulation protocols (like low-molecular-weight heparin) based on the microclotting hypothesis, though these are more experimental and carry real risks. Others promote immunoglobulin infusions or other blood-derived products. The price range is significant: a single Myers Cocktail runs $150-300, high-dose vitamin C drips $300-600, and longer protocols can cost thousands. The pitch is consistent: restore nutrients, reduce inflammation, improve cellular energy production. But here's the critical question: is there evidence this actually works?
What the Research Actually Shows (It's Limited, and That's the Honest Answer)
The evidence for IV therapy in Long COVID recovery is thin. As of early 2025, there are no large randomized controlled trials showing that Myers Cocktail, high-dose vitamin C IV, or NAD+ infusions improve Long COVID symptoms. This isn't because researchers haven't tried—it's because Long COVID is difficult to study, heterogeneous in presentation, and funding has been slow to materialize. There is emerging interest in micronutrient status in Long COVID (some patients do show deficiencies in B vitamins, magnesium, or vitamin D), which theoretically could support IV replacement. There's also lab evidence that glutathione levels may be depleted in some Long COVID patients, and that NAD+ metabolism is altered—but lab findings don't automatically mean that IV infusions will restore symptoms. Case reports and anecdotal reports from Long COVID communities on Reddit mention temporary energy improvements or mild symptom relief, but these aren't controlled observations and are vulnerable to placebo effect, natural recovery variation, and regression to the mean.
What People With Long COVID Are Actually Saying About IV Therapy
The Reddit communities r/LongCOVID and r/CVS (for ME/CFS, which shares significant overlap with Long COVID) show a mixed picture. Some users report paying for private IV therapy protocols with modest or temporary improvements in energy or mental clarity—but many acknowledge these improvements don't persist, or they're uncertain whether it was the IV therapy or just a good day. Others describe spending hundreds or thousands of dollars with no benefit. A consistent theme is desperation: people are willing to try anything because standard medical care hasn't offered solutions. What's notable is the lack of testimonials describing sustained, dramatic improvement. You see more "I felt slightly better for a few days" than "this fixed my Long COVID." Some people mention that oral supplements feel insufficient given the severity of symptoms, which drives them to IV therapy—the logic being that IV bioavailability bypasses GI absorption issues. But that reasoning applies mainly to patients with documented malabsorption, not to the general Long COVID population.
The Real Risk: False Hope Delaying Evidence-Based Treatment
Here's the uncomfortable truth: the biggest risk of pursuing IV therapy for Long COVID isn't the IV itself (serious adverse events are rare when administered by licensed clinicians). It's the opportunity cost. If you spend $2,000-5,000 on a months-long IV therapy protocol without documented benefit, you're spending money and mental energy that could go toward pacing strategies, post-exertional malaise management, autonomic dysfunction treatment (which is increasingly recognized as a key component), or rehabilitation programs designed specifically for Long COVID (like supervised graded exercise therapy, though this remains controversial for severe ME/CFS). The evidence-supported approaches for Long COVID right now are far less glamorous: careful activity management to avoid crashes, treatment of secondary conditions (dysautonomia, sleep dysfunction, depression), and participation in Long COVID research trials. Multiple trials are underway testing anticoagulation, immunomodulation, and rehabilitation, and these are where meaningful answers will come from—not from uncontrolled IV therapy clinics.
If You're Considering IV Therapy for Long COVID: Questions to Ask First
If you're still interested in pursuing IV therapy, approach it systematically. First: ask the clinic for published evidence specifically in Long COVID (not in athletic recovery or general wellness). If they can't provide peer-reviewed studies, that's your answer. Second: get baseline bloodwork. Do you actually have documented deficiencies that would justify IV repletion? Many Long COVID patients don't. Third: agree on metrics in advance. How will you measure improvement? How many sessions before you reassess? What's the stop-loss—at what point do you conclude it's not working? Fourth: discuss with your primary care doctor or Long COVID specialist. Some IV protocols (particularly anticoagulation therapies) interact with medications or underlying conditions. Fifth: be realistic about cost-benefit. If it's $300 and you have a clear deficiency, that's different from $5,000+ for an unproven protocol. Finally: don't postpone other evidence-supported symptom management while you're exploring IV therapy. Your energy is limited—use it wisely.
The Bottom Line: Hope Is Good, But Evidence Matters More
IV therapy may eventually prove helpful for Long COVID recovery. The theoretical foundations (micronutrient repletion, antioxidant support, mitochondrial optimization) aren't absurd. But we're not there yet. Right now, IV therapy for Long COVID is in the "promising hypothesis" stage, not the "proven treatment" stage. If you pursue it, do so with eyes open about what the evidence actually says (very little), what clinics are actually claiming (sometimes overreaching), and what you might be giving up (time, money, and mental energy). The most responsible Long COVID treatment strategy right now is a combination of symptom management, participation in research trials, and evidence-based rehabilitation—boring, unglamorous, but grounded in what we actually know. IV therapy might supplement that approach, but it shouldn't replace it.